Arcus Biosciences Inc (NYSE: RCUS) is -26.39% lower on its value in year-to-date trading and has touched a low of $11.55 and a high of $20.31 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The RCUS stock was last observed hovering at around $13.10 in the last trading session, with the day’s loss setting it -2.14%.
Currently trading at $10.96, the stock is -15.30% and -24.67% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 4.65 million and changing -16.34% at the moment leaves the stock -30.03% off its SMA200. RCUS registered -31.33% loss for a year compared to 6-month loss of -30.32%.
The stock witnessed a -22.38% gain in the last 1 month and extending the period to 3 months gives it a -33.29%, and is -11.97% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 8.65% over the week and 5.58% over the month.
Arcus Biosciences Inc (RCUS) has around 577 employees, a market worth around $1.00B and $263.00M in sales. Profit margin for the company is -102.66%. Distance from 52-week low is -5.11% and -46.04% from its 52-week high. The company has generated returns on investments over the last 12 months (-44.12%).
with sales reaching $31M over the same period.The EPS is expected to grow by 17.80% this year, but quarterly earnings will post 123.58% year-over-year. Quarterly sales are estimated to shrink 0.00% in year-over-year returns.
Arcus Biosciences Inc (RCUS) Top Institutional Holders
The shares outstanding are 91.50M, and float is at 48.69M with Short Float at 13.10%.
The top institutional shareholder in the company is BLACKROCK INC. with over 9.76 million shares valued at $148.69 million. The investor’s holdings represent 11.3261% of the RCUS Shares outstanding. As of 2024-06-30, the second largest holder is VANGUARD GROUP INC with 5.26 million shares valued at $80.07 million to account for 6.099 of the shares outstanding. The other top investors are WOODLINE PARTNERS LP which holds 4.25 million shares representing 4.9249% and valued at over $64.65 million, while FMR LLC holds 4.8501 of the shares totaling 4.18 million with a market value of $63.67 million.
Arcus Biosciences Inc (RCUS) Insider Activity
The most recent transaction is an insider sale by Goeltz II Robert C., the company’s Chief Financial Officer. SEC filings show that Goeltz II Robert C. sold 3,594 shares of the company’s common stock on Dec 31 ’24 at a price of $15.00 per share for a total of $53910.0. Following the sale, the insider now owns 60138.0 shares.
Still, SEC filings show that on Dec 02 ’24, Azoy Alexander (Chief Accounting Officer) disposed off 201 shares at an average price of $15.32 for $3079.0. The insider now directly holds 19,070 shares of Arcus Biosciences Inc (RCUS).
